EXPAND

WHAT’S POSSIBLE 

in neurovascular therapy

Discover the power of active technology for ischemic and hemorrhagic stroke. 

Explore Our Therapies

EXPAND

WHAT’S POSSIBLE 

in neurovascular therapy

Discover the power of active technology for ischemic and hemorrhagic stroke. 

Explore Our Therapies

Like fingerprints, no two strokes are the same. 

Yet, conventional therapy options are limited and can compromise patient safety

Like fingerprints, no two strokes are the same.   Yet, conventional therapy options are limited and can compromise patient safety

40K+

patients treated

100+

issued patents

75+

clinical publications

Our solution? Tools that adapt to each patient's anatomy.

Engineered for precise control at every step.​

Utilizing proprietary manufacturing techniques, our devices enable physicians to respond in real-time to the anatomy and tailor the procedure to every patient. 

At the forefront of advancing stroke intervention ​

Rapid Medical Announces FDA Clearance of DRIVEWIRE™ 35 and First Stroke Cases




Rapid Medical™’s TIGERTRIEVER™ 13 Demonstrates Promising 90-Day Outcomes in DISTALS Trial, Reinforcing Pivotal Safety and Efficacy Findings


Rapid Medical™’s DISTALS Trial Overwhelmingly Positive, Demonstrating Superior Reperfusion with TIGERTRIEVER™ 13 in Medium Vessel Stroke  

Rapid Medical™ Completes Enrollment in DISTALS Trial Evaluating TIGERTRIEVER 13™ for Distal Vessel Occlusions



Rapid Medical Announces FDA Clearance of DRIVEWIRE™ 35 and First Stroke Cases




Rapid Medical™’s TIGERTRIEVER™ 13 Demonstrates Promising 90-Day Outcomes in DISTALS Trial, Reinforcing Pivotal Safety and Efficacy Findings


Rapid Medical™’s DISTALS Trial Overwhelmingly Positive, Demonstrating Superior Reperfusion with TIGERTRIEVER™ 13 in Medium Vessel Stroke  

Rapid Medical™ Completes Enrollment in DISTALS Trial Evaluating TIGERTRIEVER 13™ for Distal Vessel Occlusions